Gelesis is an Italian biotech company working to improve the lives of people struggling with excess weight and metabolic diseases through its breakthrough platform, with CE- and FDA-cleared manufacturing of oral medical devices for overweight and obesity that combine efficacy and safety through a novel biomimetic approach, backed by solid pre-clinical and clinical evidence and an ambitious ongoing clinical plan.

No comments available.
Leave your rating & comment